- Home
- TZOO vs TARA Comparison
TZOO vs TARA Comparison
Compare TZOO & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TZOO
- TARA
- Stock Information
- Founded
- TZOO 1998
- TARA N/A
- Country
- TZOO United States
- TARA United States
- Employees
- TZOO N/A
- TARA N/A
- Industry
- TZOO Advertising
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TZOO Consumer Discretionary
- TARA Health Care
- Exchange
- TZOO Nasdaq
- TARA Nasdaq
- Market Cap
- TZOO 103.9M
- TARA 118.1M
- IPO Year
- TZOO 2002
- TARA N/A
- Fundamental
- Price
- TZOO $10.31
- TARA $3.21
- Analyst Decision
- TZOO Strong Buy
- TARA Strong Buy
- Analyst Count
- TZOO 3
- TARA 6
- Target Price
- TZOO $20.00
- TARA $19.80
- AVG Volume (30 Days)
- TZOO 102.1K
- TARA 135.0K
- Earning Date
- TZOO 10-22-2025
- TARA 11-11-2025
- Dividend Yield
- TZOO N/A
- TARA N/A
- EPS Growth
- TZOO N/A
- TARA N/A
- EPS
- TZOO 0.90
- TARA N/A
- Revenue
- TZOO $87,822,000.00
- TARA N/A
- Revenue This Year
- TZOO $13.13
- TARA N/A
- Revenue Next Year
- TZOO $17.91
- TARA N/A
- P/E Ratio
- TZOO $11.41
- TARA N/A
- Revenue Growth
- TZOO 3.47
- TARA N/A
- 52 Week Low
- TZOO $9.20
- TARA $1.60
- 52 Week High
- TZOO $24.85
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- TZOO 56.91
- TARA 54.04
- Support Level
- TZOO $9.30
- TARA $3.02
- Resistance Level
- TZOO $9.96
- TARA $3.20
- Average True Range (ATR)
- TZOO 0.35
- TARA 0.13
- MACD
- TZOO 0.13
- TARA -0.00
- Stochastic Oscillator
- TZOO 100.00
- TARA 67.86
About TZOO Travelzoo
Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).